- Home
- ENSC vs BNZI Comparison
ENSC vs BNZI Comparison
Compare ENSC & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- BNZI
- Stock Information
- Founded
- ENSC 2003
- BNZI 2016
- Country
- ENSC United States
- BNZI United States
- Employees
- ENSC N/A
- BNZI N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- ENSC Health Care
- BNZI
- Exchange
- ENSC Nasdaq
- BNZI Nasdaq
- Market Cap
- ENSC 9.5M
- BNZI 9.5M
- IPO Year
- ENSC N/A
- BNZI N/A
- Fundamental
- Price
- ENSC $6.07
- BNZI $1.64
- Analyst Decision
- ENSC
- BNZI Strong Buy
- Analyst Count
- ENSC 0
- BNZI 1
- Target Price
- ENSC N/A
- BNZI $125.00
- AVG Volume (30 Days)
- ENSC 154.9K
- BNZI 3.1M
- Earning Date
- ENSC 11-12-2024
- BNZI 11-14-2024
- Dividend Yield
- ENSC N/A
- BNZI N/A
- EPS Growth
- ENSC N/A
- BNZI N/A
- EPS
- ENSC N/A
- BNZI N/A
- Revenue
- ENSC $4,421,404.00
- BNZI $4,310,782.00
- Revenue This Year
- ENSC N/A
- BNZI $23.28
- Revenue Next Year
- ENSC N/A
- BNZI $66.99
- P/E Ratio
- ENSC N/A
- BNZI N/A
- Revenue Growth
- ENSC 40.41
- BNZI N/A
- 52 Week Low
- ENSC $2.12
- BNZI $1.30
- 52 Week High
- ENSC $30.90
- BNZI $222.35
- Technical
- Relative Strength Index (RSI)
- ENSC 42.77
- BNZI 47.17
- Support Level
- ENSC $5.34
- BNZI $1.34
- Resistance Level
- ENSC $8.27
- BNZI $2.66
- Average True Range (ATR)
- ENSC 1.06
- BNZI 0.22
- MACD
- ENSC -0.24
- BNZI 0.06
- Stochastic Oscillator
- ENSC 18.43
- BNZI 24.50
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.